Analytical Data
-
Gene name
MTERFD2
- Application
-
Alternative Names
FLJ16261; HSPC096; MGC61716; MTER2_HUMAN; MTERF domain containing 2; mTERF domain-containing protein 2; Mterfd2; OTTHUMP00000200479; OTTHUMP00000200519
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z6M4
-
Expression Region
43-381 aa
-
AA Sequence
LTTASNGG VIEELSCVRS NNYVQEPECR RNLVQCLLEK QGTPVVQGSL ELERVMSSLL DMGFSNAHIN ELLSVRRGAS LQQLLDIISE FILLGLNPEP VCVVLKKSPQ LLKLPIMQMR KRSSYLQKLG LGEGKLKRVL YCCPEIFTMR QQDINDTVRL LKEKCLFTVQ QVTKILHSCP SVLREDLGQL EYKFQYAYFR MGIKHPDIVK SEYLQYSLTK IKQRHIYLER LGRYQTPDKK GQTQIPNPLL KDILRVSEAE FLARTACTSV EEFQVFKKLL AREEEESESS TSDDKRASLD EDEDDDDEED NDEDDNDEDD DDEDDDEAED NDEDEDDDEE E
-
Molecular Weight
43.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MTERFD2 (Mitochondrial Translation Elongation Factor-D2) is a mitochondrial protein that plays a crucial role in the protein synthesis process within mitochondria, which are essential for cellular energy production. Recent studies have highlighted the significance of MTERFD2 in various biological processes, including mitochondrial function, cellular metabolism, and even apoptosis. The dysfunction of MTERFD2 has been linked to several pathologies, including neurodegenerative diseases and metabolic disorders, emphasizing its importance in human health. Understanding the structure and function of MTERFD2 through recombinant protein studies can provide insights into its mechanism of action and interactions with other mitochondrial components. This research has the potential to reveal novel therapeutic targets for diseases related to mitochondrial dysfunction. By producing recombinant MTERFD2 in various expression systems, researchers aim to investigate its biochemical properties, functional assays, and interactions with ribosomal subunits and tRNAs, thereby elucidating its role in mitochondrial translation. Overall, the study of MTERFD2 and its recombinant protein offers valuable contributions to the understanding of mitochondrial biology and its implications for disease treatment.
